In terms of Company’s Code of Conduct (To Regulate, Monitor and Reporting of Trading by Designated Persons) (Insider Trading Code) read with Schedule B and Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Marksans Pharma has informed that it submitted a report in respect of violation of Insider Trading Code of the Company as per format specified by SEBI vide its Circular No.SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020.
The above information is a part of company’s filings submitted to BSE.